Eli Lilly has launched a multi-year, multi-channel, global campaign, ‘Brain Health Matters’, urging people to focus on their ...

On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control ...

Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many ...

Lucy Singah has been appointed as Chief Financial Officer (CFO) at Resolution Therapeutics, with Daniel Kennedy being ...

Novo Nordisk has announced that it will be reducing its workforce globally by around 9,000 people. Currently, over 78,000 ...

Tourmaline Bio is valued at around $1.4bn, with an offer price of $48 per share, and the transaction is expected to close in ...

Morikis currently serves on the Board of Directors of United Parcel Service, General Mills and Whirlpool Corporation and as ...

Circle Pharma will leverage Lilly TuneLab to further strengthen its AI/ML capabilities and proprietary MXMO platform, which ...

Europe entered 2025 with an urgent focus on ‘competitiveness’ after a series of reports – written by respected political ...

Ryan Quigley has been appointed as the new Chief Executive Officer at Inizio. He succeeds Paul Taaffe, who will continue to ...

Invivyd has received advice from the US Food and Drug Administration (FDA) on a rapid pathway to potential Biologics License ...

PhotoPharmics has formed a commercial advisory board (CAB) to help guide the market launch of Celeste, its US Food and Drug ...